SF3B1 Mutations in CLL Are Equivalent to p53/ATM Dysfunction and Cause Defective Puma Upregulation in Response to Chemotherapy

被引：4
|
作者：
te Raa, Doreen [1 ]
Derks, Ingrid A. M. [1 ]
Luijks, Dieuwertje M. [1 ]
van Laar, Jacoline [1 ]
Monsuur, Hanneke [1 ]
Oldreive, Ceri [2 ]
Jethwa, Alexander [3 ,4 ]
Huellein, Jennifer [3 ,4 ]
Stankovic, Tatjana [2 ]
Zenz, Thorsten [5 ]
Van Oers, Marinus H. J. [1 ]
Kater, Arnon P. [1 ]
Eldering, Eric [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England
[3] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
[5] Heidelberg Univ, Heidelberg, Germany
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.711.711
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
711
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
    Nadeu, Ferran
    Delgado, Julio
    Royo, Cristina
    Baumann, Tycho
    Stankovic, Tatjana
    Pinyol, Magda
    Jares, Pedro
    Navarro, Alba
    Martin-Garcia, David
    Bea, Silvia
    Salaverria, Itziar
    Oldreive, Ceri
    Aymerich, Marta
    Suarez-Cisneros, Helena
    Rozman, Maria
    Villamor, Neus
    Colomer, Dolors
    Lopez-Guillermo, Armando
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, Maria
    Colado, Enrique
    Puente, Xose S.
    Lopez-Otin, Carlos
    Enjuanes, Anna
    Campo, Elias
    BLOOD, 2016, 127 (17) : 2122 - 2130
  • [22] Defining the observed mutual exclusivity between SF3B1 and TP53 mutations in cancer
    Bergman, Riley
    Park, Ben
    Croessmann, Sarah
    CANCER RESEARCH, 2022, 82 (12)
  • [23] CANCER-LINKED SF3B1 MUTATIONS CAUSE FAULTY SPLICING AND SUGP1 BINDING
    不详
    CANCER DISCOVERY, 2019, 9 (10) : 1336 - 1336
  • [24] Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations
    Pacholewska, Alicja
    Lienhard, Matthias
    Brueggemann, Mirko
    Haenel, Heike
    Bilalli, Lorina
    Koenigs, Anja
    Hess, Felix
    Becker, Kerstin
    Koehrer, Karl
    Kaiser, Jesko
    Gohlke, Holger
    Gattermann, Norbert
    Hallek, Michael
    Herling, Carmen D.
    Koenig, Julian
    Grimm, Christina
    Herwig, Ralf
    Zarnack, Kathi
    Schweiger, Michal R.
    GENOME RESEARCH, 2024, 34 (11) : 1832 - 1848
  • [25] NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
    Schnaiter, Andrea
    Paschka, Peter
    Rossi, Marianna
    Zenz, Thorsten
    Buehler, Andreas
    Winkler, Dirk
    Cazzola, Mario
    Doehner, Konstanze
    Edelmann, Jennifer
    Mertens, Daniel
    Kless, Sabrina
    Mack, Silja
    Busch, Raymonde
    Hallek, Michael
    Doehner, Hartmut
    Stilgenbauer, Stephan
    BLOOD, 2013, 122 (07) : 1266 - 1270
  • [26] Acquisition of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients During the Course of Disease Is Associated with an Unmutated IGHV Status and Mutations in XPO1 and SF3B1
    Grossmann, Vera
    Kohlmann, Alexander
    Schnittger, Susanne
    Weissmann, Sandra
    Dicker, Frank
    Jeromin, Sabine
    Boeck, Lucia
    Alpermann, Tamara
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    BLOOD, 2012, 120 (21)
  • [27] NOTCH1, SF3B1 and TP53 Mutations in Fludarabine-Refractory CLL Patients Treated with Alemtuzumab: Results From the CLL2H Trial of the Gcllsg
    Schnaiter, Andrea
    Rossi, Marianna
    Paschka, Peter
    Cazzola, Mario
    Doehner, Konstanze
    Edelmann, Jennifer
    Buehler, Andreas
    Kless, Sabrina
    Mertens, Daniel
    Busch, Raymonde
    Mack, Silja
    Hallek, Michael
    Doehner, Hartmut
    Stilgenbauer, Stephan
    BLOOD, 2012, 120 (21)
  • [28] SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS
    Yumin Huang
    John Hale
    Yaomei Wang
    Wei Li
    Shijie Zhang
    Jieying Zhang
    Huizhi Zhao
    Xinhua Guo
    Jing Liu
    Hongxia Yan
    Karina Yazdanbakhsh
    Gang Huang
    Christopher D. Hillyer
    Narla Mohandas
    Lixiang Chen
    Ling Sun
    Xiuli An
    Journal of Hematology & Oncology, 11
  • [29] SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS
    Huang, Yumin
    Hale, John
    Wang, Yaomei
    Li, Wei
    Zhang, Shijie
    Zhang, Jieying
    Zhao, Huizhi
    Guo, Xinhua
    Liu, Jing
    Yan, Hongxia
    Yazdanbakhsh, Karina
    Huang, Gang
    Hillyer, Christopher D.
    Mohandas, Narla
    Chen, Lixiang
    Sun, Ling
    An, Xiuli
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [30] SF3B1 Mutations Associate with Low CD20 Expression in CLL: Another NOTCH1-Dependent Mechanism?
    Pozzo, Federico
    Bittolo, Tamara
    Tissino, Erika
    Vit, Filippo
    Vendramini, Elena
    Bomben, Riccardo
    Zucchetto, Antonella
    Dal Bo, Michele
    Laurenti, Luca
    D'Arena, Giovanni Francesco
    Di Raimondo, Francesco
    Chiarenza, Annalisa
    Pozzato, Gabriele
    Zaja, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    BLOOD, 2018, 132
12345